Josh Mandel-Brehm
Direttore/Membro del Consiglio presso PROMIS NEUROSCIENCES, INC.
Patrimonio netto: - $ in data 30/06/2024
Posizioni attive di Josh Mandel-Brehm
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PROMIS NEUROSCIENCES, INC. | Direttore/Membro del Consiglio | 01/09/2021 | - |
| Independent Dir/Board Member | 01/09/2021 | - | |
Camp4 Therapeutics Corp.
 Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 01/05/2017 | - |
| Amministratore Delegato | 01/05/2017 | - | |
| Presidente | 01/05/2017 | - | |
Vico Therapeutics BV
 Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Direttore/Membro del Consiglio | 01/09/2019 | - |
| Fondatore | 01/09/2019 | - |
Storia della carriera di Josh Mandel-Brehm
Formazione di Josh Mandel-Brehm
| University of Michigan | Masters Business Admin |
| Washington University in St. Louis | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Paesi Bassi | 2 |
| Canada | 2 |
Posizioni
| Director/Board Member | 3 |
| Chief Executive Officer | 1 |
| President | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| PROMIS NEUROSCIENCES, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Camp4 Therapeutics Corp.
Camp4 Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Camp4 Therapeutics Corp. operates as a biotechnology company. The firm discovers a treatment option for patients. The company was founded by Paulina Hill and Leonard Zon on May 20, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Vico Therapeutics BV is a private biotech company based in Leiden, Netherlands that focuses on developing RNA modulating therapies for rare severe neurological disorders. The Dutch company's antisense oligonucleotide platform (AON) is directed towards different forms of spinocerebellar ataxia (SCA) and Huntington disease (HD), while its early discovery RNA editing platform is directed towards Rett syndrome. Vico Therapeutics was founded in 2019 by Luc Dochez, Josh Mandel-Brehm, Gail Mandel, and Dr. Judith van Deutekom, who have strong academic reputations and vast industry experience. Micah Mackison has been the CEO of the company since 2022. | Health Technology |
- Borsa valori
- Insiders
- Josh Mandel-Brehm
- Esperienza
